Randal Mills, President & CEO, Osiris to give Keynote at the 9th Stem Cell Conference, Philadelphia
Randal Mills, President & Chief Executive Officer of Osiris to give a Keynote Presentation at the 9th Stem Cell Research & Therapeutics Conference (Oct 24-26, 2012 in Philadelphia, PA)
MONROVIA, CA, August 10, 2012
Randal Mills, President & Chief Executive Officer of Osiris to give a Keynote Presentation at the 9th Stem Cell Research & Therapeutics Conference (Oct 24-26, 2012 in Philadelphia, PA)In May of 2012 Osiris Therapeutics, Inc. made history with their world's first approved Stem Cell Drug: Prochymal (remestemcel-L), leaving Canada the first country to approve Stem Cell Medicinal Product for Rare Disease called acute Graft-versus-Host Disease (GvHD).
"Prochymal is being evaluated in Phase 3 clinical trials for several indications, including acute graft versus host disease (GvHD) and also Crohn's disease, and is the only stem cell therapeutic currently designated by the FDA as both an Orphan Drug and Fast Track product" (www.osiris.com).
Randal Mills, Ph.D., President and Chief Executive Officer, joined Osiris in July 2004. Dr. Mills is also a member of the Board of Directors. Prior to joining Osiris, Dr. Mills was an executive officer of Regeneration Technologies, Inc. (NASDAQ - RTIX). Dr. Mills served in several leadership positions at RTI from its formation in 1998 until 2004, including Vice President of Business Development and Vice President of Operations and R&D and is credited with several key initiatives, including the development and commercialization of RTI's core technology, BioCleanse .
GTC's 9th Stem Cell Research & Therapeutics Conference, taking place on October 24-26, 2012 in Philadelphia, PA forum presents information novel advances and technologies, advanced pre-clinical disease modes, overcoming challenges in clinical development, commercialization, distribution and manufacturing, and a panel discussion on the best uses of iPS & hESC sourced pluripotent cells.
Presenting will be Top Executive Speakers from the following Companies: Osiris, ATRM, a Johnson & Johnson Company, Angiocrine Bioscience, Athersys, Bioheart, Capricor, Celgene, Cellectis Stem Cells, Eli Lilly, Genentech, GlaxoSmithKline, Janssen, NIH, Pfizer, Pluristem, Regenerative Patch Technologies, Roche, SanBio, Tengion, and many more!
To view the Program Agenda Click Here. To view the Speaker List Click Here.
For more information, please visit http://www.gtcbio.com
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com